share_log

Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M

Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M

努米納斯健康公司的第四季度和2022財年報告顯示,收入增長了464%,達到420萬美元
Benzinga Real-time News ·  2022/11/29 17:46
Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.
努米納斯健康公司。多倫多證券交易所股票代碼:NUMI)(多倫多證券交易所股票代碼:NUMIF)是一家推進創新治療和安全、循證迷幻輔助治療的精神健康護理公司,該公司週一晚間公佈了截至2022年8月31日的三個月和十二個月的財務業績。
"Fiscal 2022 was a pivotal year for Numinus, as we entered the US market with the transformational acquisition of Novamind, expanded our Ketamine-assisted Therapy offering across Canada, launched a formal practitioner training program, and unveiled a global rebranding of our company," stated Payton Nyquvest, founder and CEO. "Combined, these efforts have provided a solid platform for our continued, measured growth – with scalable infrastructure and...
“2022財年對努米納斯來説是關鍵的一年,因為我們通過對Novamind的變革性收購進入了美國市場,在加拿大擴展了我們的氯胺酮輔...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論